Artigos Científicos - ICB
URI Permanente para esta coleçãohttps://repositorio.ufpa.br/handle/2011/2152
Navegar
Navegando Artigos Científicos - ICB por CNPq "CNPQ::CIENCIAS EXATAS E DA TERRA"
Agora exibindo 1 - 2 de 2
- Resultados por página
- Opções de Ordenação
Item Acesso aberto (Open Access) Dideoxy single allele-specific PCR - DSASP new method to discrimination allelic(Universidade Federal do Pará, 2015-06) LIMA, Eleonidas Moura; LOPES, Otávio Sérgio; SOARES, Leonardo Ferreira; ARRUDA, Talitta Dantas; GIGEK, Carolina Oliveira; MELO, Cynthia Germoglio Farias; SMITH, Marília de Arruda Cardoso; OLIVEIRA, João Ricardo Gonçalves; MEDEIROS, Arnaldo Correia de; DELATORRE, Plínio; BURBANO, Rommel Mario RodriguézGastric cancer (GC) is a multifactorial disease with a high mortality rate in Brazil and worldwide. This work aimed to evaluate single nucleotide polymorphisms (SNP) rs1695, in the Glutathione S-Transferase Pi (GSTP1) gene in GC samples by comparative analysis Specific PCR - ASP and Dideoxy Single Allele-Specific PCR - DSASP methods. The DSASP is the proposed new method for allelic discrimination. This work analyzed 60 GC samples, 26 diffuse and 34 intestinal types. The SNP rs1695 of the GSTP1 gene was significantly associated with GC analyzed by DSASP method (χ 2 = 9.7, P < 0.05). A comparative analysis of the data obtained from both methods did not differ significantly (χ 2 = 0.08, P > 0.05). These results suggest that the SNP rs1695 of the GSTP1 gene was a risk factor associated with gastric carcinogens is and the DSASP method was a new successfully low-cost strategy to study allelic discrimination.Item Acesso aberto (Open Access) Human T-cell lymphotropic virus types I and II infections in a cohort of patients with neurological disorders in Belém, Pará, Brazil(Universidade Federal do Pará, 2004-02) MACÊDO, Olinda; LIMA, Telma Vitorina Ribeiro; GOMES, Maria de Lourdes Contente; LINHARES, Alexandre da Costa; LINHARES, Adriana de O.; MOURA, Antônio deSerum- and/or- cerebrospinal fluid (CSF) samples obtained from 190 patients suffering from chronic, progressive neurological disease were screened for the presence of human T-cell lymphotropic viruses type I (HTLV-I) and type II (HTLV-II) antibodies over a six-year period (1996 to 2001) in Belém, Pará, Brazil. Patients were of both sexes (male subjects, 52%) with ages ranging from 2 to 79 years (mean, 35.9). Overall, 15 (7.9%) subjects - of whom 12 (80%) were female adults - reacted HTLV-I/II-seropositive when screened by enzyme-linked immunosorbent assay (ELISA). Serum samples from 14 of these patients were also analyzed using a recombinant Western blot (WB) assay that yielded HTLV-I-, HTLV-II-, and HTLV-I/II- reactivities for 10 (71.4%), 3 (21.4%) and 1 (7.2%) of them, respectively. The yearly rates of HTLV-I/II antibodies ranged from 2.6% (2001) to 21.7% (2000), with progressively increasing seropositivities from 1998 to 2000. Altogether, walking difficulty (n = 5 subjects), spasticity (n = 4) and leg weakness (n = 3) accounted for 80% of symptoms recorded among the 15 patients whose sera had antibodies to HTLV-I/II as detected by ELISA. These findings provide evidence that both HTLV-I and HTLV-II play a role in the development of chronic myelopathy in Belém, Pará, Northern Brazil.